Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Horsmans

Showing results (11-20 of 166) with videos related to

Pageof 17
Sort By:
Acta Gastro-Enterologica Belgica|January 1, 1991
[Secondary drug-induced cholestasis with bile duct involvement]Y Horsmans, C Harvengt
Journal De Radiologie|November 11, 2006
[Calcified portal vein thrombosis in the follow-up of surgical portocaval shunt: Sonographic findings and differential diagnosis]E Danse, Y Horsmans
Critical Care Medicine|October 6, 2001
Intravenous omeprazole in critically ill patients: a randomized, crossover study comparing 40 with 80 mg plus 8 mg/hour on intragastric pHP F Laterre, Y Horsmans
Annals of Internal Medicine|October 15, 1996
Pruritus associated with cholestatic liver diseaseY Horsmans, A P Geubel
Pharmacy World & Science : PWS|November 20, 1998
Effect of hepatic insufficiency on pharmacokinetics and drug dosingR K Verbeeck, Y Horsmans
Clinical Pharmacokinetics|November 1, 1996
Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitorsJ P Desager, Y Horsmans
Lancet (London, England)|May 13, 1995
Symptomatic myopathy in hepatitis C infection without interferon therapyY Horsmans, A P Geubel
Clinical Pharmacokinetics|May 1, 1995
Pharmacokinetic-pharmacodynamic relationships of H1-antihistaminesJ P Desager, Y Horsmans
Journal of Hepatology|November 1, 1994
Amoxycillin-clavulanic acid-erythromycin cross-liver toxicity: a case reportY Horsmans, A P Geubel
Acta Gastro-Enterologica Belgica|May 1, 1994
[Chronic viral hepatitis and interferons: preliminary results in 60 patients with chronic hepatitis C and cellular mechanism of action]R Brenard, Y Horsmans, A Geubel
Pageof 17

Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
Acta Gastro-Enterologica Belgica|January 1, 1991
[Secondary drug-induced cholestasis with bile duct involvement]Y Horsmans, C Harvengt
Journal De Radiologie|November 11, 2006
[Calcified portal vein thrombosis in the follow-up of surgical portocaval shunt: Sonographic findings and differential diagnosis]E Danse, Y Horsmans
Critical Care Medicine|October 6, 2001
Intravenous omeprazole in critically ill patients: a randomized, crossover study comparing 40 with 80 mg plus 8 mg/hour on intragastric pHP F Laterre, Y Horsmans
Annals of Internal Medicine|October 15, 1996
Pruritus associated with cholestatic liver diseaseY Horsmans, A P Geubel
Pharmacy World & Science : PWS|November 20, 1998
Effect of hepatic insufficiency on pharmacokinetics and drug dosingR K Verbeeck, Y Horsmans
Clinical Pharmacokinetics|November 1, 1996
Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitorsJ P Desager, Y Horsmans
Lancet (London, England)|May 13, 1995
Symptomatic myopathy in hepatitis C infection without interferon therapyY Horsmans, A P Geubel
Clinical Pharmacokinetics|May 1, 1995
Pharmacokinetic-pharmacodynamic relationships of H1-antihistaminesJ P Desager, Y Horsmans
Journal of Hepatology|November 1, 1994
Amoxycillin-clavulanic acid-erythromycin cross-liver toxicity: a case reportY Horsmans, A P Geubel
Acta Gastro-Enterologica Belgica|May 1, 1994
[Chronic viral hepatitis and interferons: preliminary results in 60 patients with chronic hepatitis C and cellular mechanism of action]R Brenard, Y Horsmans, A Geubel
Pageof 17